These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30706477)

  • 21. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes.
    Han CY; Chiba T; Campbell JS; Fausto N; Chaisson M; Orasanu G; Plutzky J; Chait A
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1806-13. PubMed ID: 16709944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of expression of apolipoprotein A-I by selenium status in human liver hepatoblastoma cells.
    Stahle JA; Vunta H; Channa Reddy C; Sandeep Prabhu K
    Eur J Nutr; 2009 Aug; 48(5):283-90. PubMed ID: 19294445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium Propionate or Sodium Butyrate Promotes Fatty Acid Oxidation in HepG2 Cells Under Oxidative Stress.
    Cook KJ; Coulter A; Keenan M; Greenway F; Losso JN
    J Med Food; 2023 Jan; 26(1):74-79. PubMed ID: 36637439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor α stimulates endogenous apolipoprotein A-I expression and secretion by human monocytes and macrophages: role of MAP-kinases, NF-κB, and nuclear receptors PPARα and LXRs.
    Shavva VS; Mogilenko DA; Nekrasova EV; Trulioff AS; Kudriavtsev IV; Larionova EE; Babina AV; Dizhe EB; Missyul BV; Orlov SV
    Mol Cell Biochem; 2018 Nov; 448(1-2):211-223. PubMed ID: 29442267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
    Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
    Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiated CaCo-2 cells as an in-vitro model to evaluate de-novo apolipoprotein A-I production in the small intestine.
    Dullens SP; Mensink RP; Mariman EC; Plat J
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):642-9. PubMed ID: 19445040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response.
    Hennuyer N; Poulain P; Madsen L; Berge RK; Houdebine LM; Branellec D; Fruchart JC; Fiévet C; Duverger N; Staels B
    Circulation; 1999 May; 99(18):2445-51. PubMed ID: 10318668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between peroxisome proliferator-activated receptor alpha activity and cellular concentration of 14 perfluoroalkyl substances in HepG2 cells.
    Rosenmai AK; Ahrens L; le Godec T; Lundqvist J; Oskarsson A
    J Appl Toxicol; 2018 Feb; 38(2):219-226. PubMed ID: 28857218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease.
    Mikael LG; Genest J; Rozen R
    Circ Res; 2006 Mar; 98(4):564-71. PubMed ID: 16439690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha.
    Blanquart C; Mansouri R; Paumelle R; Fruchart JC; Staels B; Glineur C
    Mol Endocrinol; 2004 Aug; 18(8):1906-18. PubMed ID: 15131257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of apolipoprotein A-I gene expression by black seed (Nigella sativa) extracts.
    Haas MJ; Onstead-Haas LM; Naem E; Wong NC; Mooradian AD
    Pharm Biol; 2014 Sep; 52(9):1119-27. PubMed ID: 24635344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
    Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
    J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes.
    Watt MJ; Southgate RJ; Holmes AG; Febbraio MA
    J Mol Endocrinol; 2004 Oct; 33(2):533-44. PubMed ID: 15525607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
    Kockx M; Princen HM; Kooistra T
    Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of PPARα in the attenuation of bile acid-induced apoptosis by omega-3 long-chain polyunsaturated fatty acids in cultured hepatocytes.
    Tillman EM; Guan P; Howze TJ; Helms RA; Black DD
    Pediatr Res; 2016 May; 79(5):754-8. PubMed ID: 26756785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An experimental study on amelioration of dyslipidemia-induced atherosclesis by Clematichinenoside through regulating Peroxisome proliferator-activated receptor-α mediated apolipoprotein A-I, A-II and C-III.
    Liu C; Guo Q; Lu M; Li Y
    Eur J Pharmacol; 2015 Aug; 761():362-74. PubMed ID: 25979856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Association between peroxisome proliferator-activated receptor and gene-gene interactions with the apolipoprotein A I/apolipoprotein B100 ratio].
    Hai B; Ni C; Xie H; Guo Z; Wu M; Chen Q; Zhou Z; Fan W; Zhou H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Apr; 43(4):328-33. PubMed ID: 26082365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginsenoside Rf, a component of ginseng, regulates lipoprotein metabolism through peroxisome proliferator-activated receptor alpha.
    Lee H; Gonzalez FJ; Yoon M
    Biochem Biophys Res Commun; 2006 Jan; 339(1):196-203. PubMed ID: 16297877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.
    Kamarajugadda S; Becker JR; Hanse EA; Mashek DG; Mashek MT; Hendrickson AM; Mullany LK; Albrecht JH
    Oncotarget; 2016 Jul; 7(30):47674-47686. PubMed ID: 27351284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of a PPARalpha agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio.
    Schultze AE; Alborn WE; Newton RK; Konrad RJ
    J Lipid Res; 2005 Aug; 46(8):1591-5. PubMed ID: 15897610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.